May 14, 2014 — The Department of Health and Human Services (HHS) announced that new preliminary data show an overall 9 ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
May 14, 2014 — Data presented during Heart Rhythm 2014 found the use of quadripolar leads reduced the number of ...
May 13, 2014 — Esaote North America received U.S. Food and Drug Administration (FDA) clearance to market and sell its ...
May 12, 2014 — Datascope Corp./Maquet initiated a voluntary worldwide field correction of some of its intra-aortic ...
May 9, 2013 — Medical device executives from across the region are not sure the influx of new patients using their ...
May 8, 2014 — Abbott announced its catheter-based MitraClip therapy has received Health Canada approval, providing ...
May 8, 2014 — The past year has been a turbulent one for U.S. physicians, according to the 2014 Practice Profitability ...
May 7, 2014 — HeartWare Intl. Inc. issued a voluntary Urgent Medical Device Correction related to all HeartWare ...
May 7, 2014 — GE Healthcare received U.S. Food and Drug Administration (FDA) clearance for its Discovery IGS 740, a new ...
May 5, 2014 — W. L. Gore & Associates (Gore) announced that Himanshu Patel, M.D. and David Williams, M.D. at The ...
May 5, 2014 — The U.S. Food and Drug Administration (FDA) MSC Consortium is a large team of FDA scientists studying ...
May 2, 2014 — Medtronic Inc. revealed new data demonstrating positive outcomes for extreme risk patients with severe ...
May 1, 2014 — Nuance Communications announced the immediate availability of the Nuance PowerShare network, the industry ...
April 30, 2014 — Celladon Corp. announced its lead product candidate, Mydicar, has been granted breakthrough therapy ...